Diabetes Signs May Be Present 20 Years Before Diagnosis

This article originally appeared here.
Share this content:
Diabetes Signs May Be Present 20 Years Before Diagnosis
Diabetes Signs May Be Present 20 Years Before Diagnosis

FRIDAY, Feb. 9, 2018 (HealthDay News) -- Risk of developing type 2 diabetes (T2D) is associated with subtle elevations of glucose and lipids more than 20 years before diagnosis, according to a study published online Feb. 5 in Diabetes, Obesity and Metabolism.

Håkan Malmström, from the Karolinska Institutet in Stockholm, and colleagues assessed data from 296,428 individuals participating in the Swedish AMORIS cohort. All had a fasting glucose from a health exam during the baseline period (1985 to 1996) and were followed through 2012.

The researchers found that 28,244 new T2D cases were identified over the study period, yielding an average 20-year risk of 8.1 percent. Overweight and obese subjects and those with elevated fasting glucose (fGlu) and triglycerides (TG) had a substantially increased risk among both men and women. More than 20 years before diagnosis, T2D cases had higher mean body mass index, fGlu, and TG versus controls. The difference in fGlu between those who developed T2D and controls increased over time.

"This suggests that diabetogenic processes tied to chronic insulin resistance operate for decades prior to the development of T2D," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »